• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study
CONCLUSION: Patients with T2DM represent almost half of patients with CRS and are younger than their non-diabetic counterparts. T2DM doubles the risk of CRS and increases the risk of death, cardiovascular outcome, and end-stage kidney disease but not ischemic stroke after CRS.PMID:36931430 | DOI:10.1016/j.diabet.2023.101441
Source: Diabetes and Metabolism - March 17, 2023 Category: Endocrinology Authors: Valentin Maisons Jean-Michel Halimi Gr égoire Fauchier Jean-Baptiste de Fr éminville Nicolas Goin Juliette Gueguen Philippe Gatault B énédicte Sautenet Denis Angoulvant Julien Herbert Arnaud Bisson Pierre-Henri Ducluzeau Laurent Fauchier Source Type: research

A model of poorly controlled type 1 diabetes mellitus and its treatment with aerobic exercise training.
CONCLUSIONS: Together, this study demonstrates that despite moderate hyperglycaemia, the combined role of a ten-week exercise training program coupled with insulin therapy is able to alleviate many of the well-known complications associated with diabetes progression. PMID: 23522732 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - March 19, 2013 Category: Endocrinology Authors: Melling CW, Grisé KN, Hasilo CP, Fier B, Milne KJ, Karmazyn M, Noble EG Tags: Diabetes Metab Source Type: research

Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: A cohort study of 8486 primary-care patients.
CONCLUSION: Increased BMI within the first 18 months of type 2 diabetes diagnosis was associated with an increased long-term risk of CVD mortality. However, BMI decrease did not lower the long-term risk of mortality. PMID: 23871502 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - July 18, 2013 Category: Endocrinology Authors: Bodegard J, Sundström J, Svennblad B, Ostgren CJ, Nilsson PM, Johansson G Tags: Diabetes Metab Source Type: research

Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
Abstract Recent recommendations regarding type 2 diabetes (T2D) patients' treatments have focused on personalizing glycosylated haemoglobin (HbA1c) targets. Because the relationship between HbA1c and diabetes prognosis has been established from large prospective cohorts, it is valid to question the extrapolation from population-based risk reduction estimations to individual predictions. Our study aimed to investigate the relationship between HbA1c reductions and clinical outcomes in randomized controlled trials (RCTs), using a meta-regression approach. Included were RCTs comparing intensive vs. standard glucose-lo...
Source: Diabetes and Metabolism - May 6, 2015 Category: Endocrinology Authors: Bejan-Angoulvant T, Cornu C, Archambault P, Tudrej B, Audier P, Brabant Y, Gueyffier F, Boussageon R Tags: Diabetes Metab Source Type: research

Actinic keratosis and diabetes complications: A nationwide population-based study in South Korea (2009-2015).
CONCLUSION: This study has revealed that the incidence of AK is higher in diabetes patients with ocular, renal and cardiovascular complications. PMID: 29249611 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - November 29, 2017 Category: Endocrinology Authors: Bok Lee Y, Hyun Lee J, Young Choi J, Soo Yu D, Do Han K, Gyu Park Y Tags: Diabetes Metab Source Type: research

Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients.
CONCLUSION: Similar to HbA1c, higher HGI is related to higher risk of cardiovascular events in patients with T2DM without CVD. As HbA1c has proved to be a comparable risk factor, and obtaining and interpreting the HGI is complicated, any additional benefit of applying the HGI in clinical settings is likely to be limited. PMID: 29784563 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - May 8, 2018 Category: Endocrinology Authors: Østergaard HB, Mandrup-Poulsen T, Berkelmans GFN, van der Graaf Y, Visseren FLJ, Westerink J, SMART Study Group Tags: Diabetes Metab Source Type: research

Association of C-peptide with diabetic vascular complications in type 2 diabetes.
CONCLUSION: -: C-peptide was positively associated with CVD, but inversely associated with DR progression. The association between C-peptide and CVD could be due to associated metabolic risk factors. PMID: 31026551 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - April 22, 2019 Category: Endocrinology Authors: Wang Y, Wan H, Chen Y, Xia F, Zhang W, Wang C, Fang S, Zhang K, Li Q, Wang N, Lu Y Tags: Diabetes Metab Source Type: research

Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes.
CONCLUSION: - These results suggest that NAFLD and significant LF (as assessed by FibroScan) are very commonly seen in T2DM outpatients with no known liver disease attending a secondary-care diabetes service, and that increased LF is associated with a greater proportion of chronic vascular complications, especially CKD. PMID: 31786361 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - November 27, 2019 Category: Endocrinology Authors: Mantovani A, Turino T, Lando MG, Gjini K, Byrne CD, Zusi C, Ravaioli F, Colecchia A, Maffeis C, Salvagno G, Lippi G, Bonora E, Targher G Tags: Diabetes Metab Source Type: research

SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus.
CONCLUSION: Among T2DM patients initiating fourth-line therapy, SGLT2i users had significant benefits in lowering risk of CVD, and potential benefits in lowering risks of ESRD and all-cause mortality. SGLT2i was the preferred fourth-line glucose-lowering medication least likely to be associated with complication risks. PMID: 33039672 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - October 8, 2020 Category: Endocrinology Authors: Wong CKH, Tang EHM, Man KKC, Chan EWY, Wong ICK, Lam CLK Tags: Diabetes Metab Source Type: research

Comment on "Elevated triglyceride-glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study"
Diabetes Metab. 2021 Dec 18:101314. doi: 10.1016/j.diabet.2021.101314. Online ahead of print.NO ABSTRACTPMID:34933119 | DOI:10.1016/j.diabet.2021.101314
Source: Diabetes and Metabolism - December 21, 2021 Category: Endocrinology Authors: Roomi Raja Satesh Kumar Source Type: research

Pages: 1  2  3  4  5